HRP20161354T1 - Argininske soli agonista tlr7 - Google Patents
Argininske soli agonista tlr7 Download PDFInfo
- Publication number
- HRP20161354T1 HRP20161354T1 HRP20161354TT HRP20161354T HRP20161354T1 HR P20161354 T1 HRP20161354 T1 HR P20161354T1 HR P20161354T T HRP20161354T T HR P20161354TT HR P20161354 T HRP20161354 T HR P20161354T HR P20161354 T1 HRP20161354 T1 HR P20161354T1
- Authority
- HR
- Croatia
- Prior art keywords
- salt
- ethoxy
- arginine
- phosphonoethoxy
- naphthyridin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261608011P | 2012-03-07 | 2012-03-07 | |
| PCT/EP2013/054548 WO2013131985A1 (en) | 2012-03-07 | 2013-03-07 | Immunologically useful arginine salts |
| EP13708142.8A EP2822947B1 (en) | 2012-03-07 | 2013-03-07 | Arginine salts of a tlr7 agonist |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20161354T1 true HRP20161354T1 (hr) | 2016-12-02 |
Family
ID=47843276
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20161354TT HRP20161354T1 (hr) | 2012-03-07 | 2013-03-07 | Argininske soli agonista tlr7 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US9320748B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2822947B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6325986B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN104203946B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2013229466A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2865759C (cg-RX-API-DMAC7.html) |
| CY (1) | CY1118091T1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK2822947T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2597755T3 (cg-RX-API-DMAC7.html) |
| HR (1) | HRP20161354T1 (cg-RX-API-DMAC7.html) |
| HU (1) | HUE030175T2 (cg-RX-API-DMAC7.html) |
| LT (1) | LT2822947T (cg-RX-API-DMAC7.html) |
| MX (1) | MX346678B (cg-RX-API-DMAC7.html) |
| PL (1) | PL2822947T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT2822947T (cg-RX-API-DMAC7.html) |
| RU (1) | RU2014140336A (cg-RX-API-DMAC7.html) |
| SI (1) | SI2822947T1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2013131985A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA026401B1 (ru) | 2009-09-02 | 2017-04-28 | Новартис Аг | Иммуногенные композиции, содержащие модуляторы активности tlr |
| ES2458355T3 (es) | 2010-09-01 | 2014-05-05 | Novartis Ag | Adsorción de inmunopotenciadores sobre sales metálicas insolubles |
| BR112013022397A2 (pt) | 2011-03-02 | 2017-09-26 | Derek OHagan | vacinas combinadas com doses menores de antígeno e/ou adjuvante |
| RU2014140521A (ru) | 2012-03-08 | 2016-04-27 | Новартис Аг | Адъювантные составы бустерных вакцин |
| JP6894237B2 (ja) | 2014-03-26 | 2021-06-30 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | 変異体ブドウ球菌抗原 |
| EP3061826A1 (en) | 2015-02-27 | 2016-08-31 | Novartis AG | Flavivirus replicons |
| US20230110516A1 (en) * | 2020-03-01 | 2023-04-13 | Dynavax Technologies Corporation | Coronavirus vaccines comprising a tlr9 agonist |
| WO2022192097A1 (en) * | 2021-03-06 | 2022-09-15 | Mind Medicine, Inc. | Formulations of psilocin that have enhanced stability |
| GB202215414D0 (en) | 2022-10-18 | 2022-11-30 | Glaxosmithkline Biologicals Sa | Vaccine |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6699474B1 (en) | 1990-08-20 | 2004-03-02 | Erich Hugo Cerny | Vaccine and immunserum against drugs of abuse |
| DE69334197T2 (de) | 1992-03-02 | 2008-12-11 | Novartis Vaccines And Diagnostics S.R.L. | Helicobacter pylori Cytotoxin verwendbar in Impfstoffe und Diagnostik |
| FR2718452B1 (fr) | 1994-04-06 | 1996-06-28 | Pf Medicament | Elément d'immunogène, agent immunogène, composition pharmaceutique et procédé de préparation. |
| AU695769B2 (en) | 1994-07-01 | 1998-08-20 | Provost Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin, The | Helicobacter proteins and vaccines |
| DK0909323T3 (da) | 1996-01-04 | 2007-05-21 | Novartis Vaccines & Diagnostic | Helicobacter pylori-bakterioferritin |
| GB9828000D0 (en) | 1998-12-18 | 1999-02-10 | Chiron Spa | Antigens |
| CA2414884A1 (en) | 2000-07-03 | 2002-01-10 | Chiron S.P.A. | Immunisation against chlamydia pneumoniae |
| FR2827605B1 (fr) | 2001-07-20 | 2004-07-16 | Pf Medicament | Nouveaux peptides derives de la proteine g du vrs et leur utilisation dans un vaccin |
| WO2003049762A2 (en) | 2001-12-12 | 2003-06-19 | Chiron Srl. | Immunisation against chlamydia trachomatis |
| GB0211118D0 (en) | 2002-05-15 | 2002-06-26 | Polonelli Luciano | Vaccines |
| EP2353608B1 (en) | 2002-10-11 | 2019-12-18 | Novartis Vaccines and Diagnostics S.r.l. | Polypeptide-vaccines for broad protection against hypervirulent meningococcal lineages |
| CN1812809A (zh) | 2003-06-26 | 2006-08-02 | 希龙公司 | 用于沙眼衣原体的免疫原性组合物 |
| CA2557353A1 (en) | 2004-03-02 | 2005-09-15 | Chiron Corporation | Immunogenic compositions for chlamydia pneunomiae |
| SG160329A1 (en) | 2005-02-18 | 2010-04-29 | Novartis Vaccines & Diagnostic | Proteins and nucleic acids from meningitis/sepsis-associated escherichia coli |
| NZ599345A (en) | 2005-02-18 | 2013-07-26 | Novartis Vaccines & Diagnostic | Immunogens from uropathogenic Escherichia Coli |
| CA2608278A1 (en) | 2005-05-12 | 2006-12-28 | Guido Grandi | Immunogenic compositions for chlamydia trachomatis |
| GB0524066D0 (en) | 2005-11-25 | 2006-01-04 | Chiron Srl | 741 ii |
| US8481057B2 (en) | 2005-12-22 | 2013-07-09 | Novartis Vaccines & Diagnostics Srl | Chlamydial antigens |
| CA2659552A1 (en) | 2006-08-16 | 2008-02-21 | Novartis Ag | Immunogens from uropathogenic escherichia coli |
| NZ584683A (en) | 2007-10-19 | 2012-05-25 | Novartis Ag | Neisseria meningitidis serogroup B vaccine formulations |
| ES2565377T3 (es) | 2009-04-14 | 2016-04-04 | Glaxosmithkline Biologicals Sa | Composiciones para inmunización contra Staphylococcus aureus |
| CN102481354A (zh) | 2009-06-01 | 2012-05-30 | 诺华有限公司 | 肺炎球菌RrgB分化枝的组合物 |
| AU2010258677B2 (en) * | 2009-06-10 | 2016-10-06 | Glaxosmithkline Biologicals S.A. | Benzonaphthyridine-containing vaccines |
| JP2013502918A (ja) | 2009-08-27 | 2013-01-31 | ノバルティス アーゲー | 髄膜炎菌ｆＨＢＰ配列を含むハイブリッドポリペプチド |
| TWI445708B (zh) * | 2009-09-02 | 2014-07-21 | Irm Llc | 作為ｔｌｒ活性調節劑之化合物及組合物 |
| EA026401B1 (ru) | 2009-09-02 | 2017-04-28 | Новартис Аг | Иммуногенные композиции, содержащие модуляторы активности tlr |
| ES2458355T3 (es) | 2010-09-01 | 2014-05-05 | Novartis Ag | Adsorción de inmunopotenciadores sobre sales metálicas insolubles |
| US10286056B2 (en) | 2011-01-27 | 2019-05-14 | Glaxosmithkline Biologicals S.A. | Adjuvant nanoemulsions with crystallisation inhibitors |
| WO2013030378A1 (en) * | 2011-09-01 | 2013-03-07 | Novartis Ag | Adjuvanted formulations of staphylococcus aureus antigens |
-
2013
- 2013-03-07 RU RU2014140336A patent/RU2014140336A/ru not_active Application Discontinuation
- 2013-03-07 JP JP2014560367A patent/JP6325986B2/ja active Active
- 2013-03-07 EP EP13708142.8A patent/EP2822947B1/en active Active
- 2013-03-07 HR HRP20161354TT patent/HRP20161354T1/hr unknown
- 2013-03-07 PT PT137081428T patent/PT2822947T/pt unknown
- 2013-03-07 US US14/381,513 patent/US9320748B2/en active Active
- 2013-03-07 MX MX2014010423A patent/MX346678B/es active IP Right Grant
- 2013-03-07 AU AU2013229466A patent/AU2013229466A1/en not_active Abandoned
- 2013-03-07 PL PL13708142T patent/PL2822947T3/pl unknown
- 2013-03-07 HU HUE13708142A patent/HUE030175T2/en unknown
- 2013-03-07 ES ES13708142.8T patent/ES2597755T3/es active Active
- 2013-03-07 CN CN201380012851.1A patent/CN104203946B/zh active Active
- 2013-03-07 SI SI201330288A patent/SI2822947T1/sl unknown
- 2013-03-07 CA CA2865759A patent/CA2865759C/en active Active
- 2013-03-07 LT LTEP13708142.8T patent/LT2822947T/lt unknown
- 2013-03-07 DK DK13708142.8T patent/DK2822947T3/en active
- 2013-03-07 WO PCT/EP2013/054548 patent/WO2013131985A1/en not_active Ceased
-
2016
- 2016-10-10 CY CY20161101006T patent/CY1118091T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2014010423A (es) | 2014-09-22 |
| US9320748B2 (en) | 2016-04-26 |
| CN104203946A (zh) | 2014-12-10 |
| RU2014140336A (ru) | 2016-04-27 |
| EP2822947B1 (en) | 2016-08-03 |
| AU2013229466A1 (en) | 2014-09-04 |
| DK2822947T3 (en) | 2016-09-19 |
| CA2865759C (en) | 2020-07-21 |
| SI2822947T1 (sl) | 2016-10-28 |
| ES2597755T3 (es) | 2017-01-20 |
| US20150125475A1 (en) | 2015-05-07 |
| LT2822947T (lt) | 2016-10-10 |
| CA2865759A1 (en) | 2013-09-12 |
| PT2822947T (pt) | 2016-09-26 |
| JP2015511957A (ja) | 2015-04-23 |
| MX346678B (es) | 2017-03-29 |
| PL2822947T3 (pl) | 2017-01-31 |
| CY1118091T1 (el) | 2017-06-28 |
| WO2013131985A1 (en) | 2013-09-12 |
| CN104203946B (zh) | 2017-03-22 |
| JP6325986B2 (ja) | 2018-05-16 |
| HUE030175T2 (en) | 2017-04-28 |
| EP2822947A1 (en) | 2015-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20161354T1 (hr) | Argininske soli agonista tlr7 | |
| JP2013172734A5 (cg-RX-API-DMAC7.html) | ||
| JP2015511957A5 (cg-RX-API-DMAC7.html) | ||
| FR2959742B1 (fr) | Procede de preparation d'amino-acides ou esters satures comprenant une etape de metathese | |
| EP3421468A3 (en) | Methods of preparing inhibitors of influenza viruses replication | |
| JP2014525429A5 (cg-RX-API-DMAC7.html) | ||
| FR2982610B1 (fr) | Procede de preparation de sel d'anion pentacylique | |
| JP2014218522A5 (cg-RX-API-DMAC7.html) | ||
| HRP20151397T1 (hr) | DERIVATI PIRAZOLOSPIROKETONA, NAMIJENJENI UPOTREBI KAO INHIBITORI ACETIL-CoA-KARBOKSILAZE | |
| RU2013139873A (ru) | Опорные отметки для идентификации точки начала в системах определения оптической формы | |
| WO2014207708A3 (en) | Amino acid and peptide conjugates and conjugation process | |
| IL285262A (en) | Process for the preparation of fulvestrant 3-boronic acid | |
| EP2822972A4 (en) | IMPROVED METHOD FOR THE PRODUCTION OF A PHYSIOLOGICALLY ACTIVE POLYPEPTIDE COMPLEX | |
| WO2015011119A3 (en) | Salts of dasatinib in amorphous form | |
| CA2899024C (en) | Crystalline forms of {[1-cyano-5-(4-chlorophenoxy)-4-hydroxy-isoquinoline-3-carbonyl]-amino}-acetic acid | |
| EP2773672A4 (en) | PROCESS FOR PREPARING A PHYSIOLOGICALLY ACTIVE POLYPEPTIDE COMPLEX | |
| FR2978763B1 (fr) | Procede de preparation d'amino-acides ou esters comprenant une etape de metathese | |
| GB2519787B (en) | Process for the preparation of herbicidal carboxylic acid salts | |
| CR20140462A (es) | Sales de 5-[(1r)-2-({2-[4-(2,2-difluoro-2-feniletoxi)fenil]etil} amino) -1-hidroxietil]-8-hidroquinolin-2(1h)-ona | |
| FR2999086B1 (fr) | Composition orale et/ou buccale sous forme de film fin d'un principe actif faiblement soluble, son procede de preparation et son utilisation | |
| EP2711373A4 (en) | AMORPHIC ASIAN TROMETHAMINE SALT AND MANUFACTURING METHOD THEREFOR | |
| FR2995684B1 (fr) | Procede de detection et de dosage de l'acide fluorhydrique au sein d'un electrolyte a base d'hexafluorophosphate de lithium lipf6 pour des batteries au lithium | |
| WO2012149077A3 (en) | Vision system for robotic attacher | |
| FR2994178B1 (fr) | Procede de preparation d'un acide carboxylique ou d'un aldehyde | |
| FR3053336B1 (fr) | Procede de preparation de l'acide 2,5-furane dicarboxylique (fdca) a partir de derives de pentoses |